er cells," says Charles Eberhart, M.D., Ph.D., associate professor of pathology, ophthalmology and oncology. "But the new work shows the hedgehog blockade may halt another powerful cell-survival signal, and lovastatin could provide the added boost necessary to kill more cancer cells."
Specifically, Eberhart found links between the expression of key hedgehog-related genes in medulloblastoma cells and another cell signal already tied to cancer, Bcl-2. Eberhart and his team believed that combination of a hedgehog blockade and a pro-apoptosis drug like lovastatin would kill more cancer cells.
"Our experiments suggest that hedgehog's action is woven together with Bcl-2, best known for its role in causing B-cell lymphomas," he says. "Cancer cells thwart suicide by overproducing Bcl-2, assuring them a long life."
When the Hopkins researchers noticed that Bcl-2 and hedgehog expression increased in tandem in medulloblastoma cells, they tried adding hedgehog-blocking cyclopamine to the cells and found that Bcl-2 production dwindled and tumor cells died off.
Lead author and pathology fellow Eli E. Bar, Ph.D., said he was "surprised by the degree to which the drug combination was so effective."
According to Eberhart, only half of children with medulloblastoma survive. "And those that do survive can suffer debilitating side effects caused by current toxic therapies."
'"/>Source:
Johns Hopkins Medical Institutions
Page: 1 2 Related biology news :1.
Statins have neutral effect on risk of cancer2.
Statins stop hepatitis C virus from replicating3.
Statin treatment improves spatial memory in mouse models of Alzheimers4.
Viral DNA sequence a possible trigger for breast cancer5.
Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer6.
Its not all genetic: Common epigenetic problem doubles cancer risk in mice7.
Columbia research lifts major hurdle to gene therapy for cancer8.
Combination therapy boosts effectiveness of telomere-directed cancer cell death9.
Mitochondrial DNA mutations play significant role in prostate cancer10.
New imaging method gives early indication if brain cancer therapy is effective, U-M study shows11.
BRCA1 causes ovarian cancer through indirect, biochemical route